跳至主要内容
临床试验/NCT00828113
NCT00828113已完成4 期

Long-term Varenicline Treatment for Smoking Cessation

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2009年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
101
试验地点
1
主要终点
Number of Participants Not Smoking in the Previous 7 Days, Confirmed by Expired Carbon Monoxide Reading < 10 Parts Per Million at Week 52

研究概览

简要总结

This is a clinical study of the efficacy and safety of up to 52 weeks of varenicline therapy in conjunction with individual counseling for smoking cessation. Adult volunteers in generally good health, smoking 5 or more cigarettes per day, will receive 13 weeks of open-label varenicline therapy. At 12 weeks after their target quit date, they will be assigned in a random, double-blind manner to either 40 additional weeks of varenicline or placebo. It is hypothesized that biochemically-confirmed abstinence rates will be higher for the varenicline group at 52 weeks. Participants will be followed for an additional 26 weeks post-treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • daily smoker
  • 5+ cigarettes per day for at least one year
  • expired carbon monoxide level of 5+ ppm

排除标准

  • current use of smoking cessation pharmacotherapies
  • current or history of psychotic disorder
  • current major depressive disorder
  • history of suicidal ideation in the previous 3 months
  • unstable medical condition
  • pregnant, nursing, or planning to become pregnant
  • planning to move from study area within 18 months

研究组 & 干预措施

Extended treatment

Experimental

52-week varenicline therapy + individual smoking cessation counseling

干预措施: varenicline (Drug)

Extended treatment

Experimental

52-week varenicline therapy + individual smoking cessation counseling

干预措施: Individual smoking cessation counseling (Behavioral)

Standard treatment

Active Comparator

13 weeks of varenicline therapy + individual smoking cessation counseling

干预措施: varenicline (Drug)

Standard treatment

Active Comparator

13 weeks of varenicline therapy + individual smoking cessation counseling

干预措施: Individual smoking cessation counseling (Behavioral)

结局指标

主要结局

Number of Participants Not Smoking in the Previous 7 Days, Confirmed by Expired Carbon Monoxide Reading < 10 Parts Per Million at Week 52

时间窗: 7-day point prevalence

Self-report of no smoking (not even a puff) in the previous seven days confirmed by an expired carbon monoxide reading of \< 10 parts per million as assessed at Week 52

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验